ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells.
Wan J, Wu Y, Huang L, Tian Y, Ji X, Abdelaziz MH, Cai W, Dineshkumar K, Lei Y, Yao S, Sun C, Su Z, Wang S, Xu H.
Wan J, et al. Among authors: sun c.
Cancer Lett. 2021 Apr 1;502:34-43. doi: 10.1016/j.canlet.2021.01.002. Epub 2021 Jan 9.
Cancer Lett. 2021.
PMID: 33429004